Caring for women with childbearing potential taking teratogenic dermatologic drugs: Guidelines for practice

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 46, Issue 2 SUPPL., 2001, Pages 153-161

  Perlman, Sally E ^a   Rudy, Sherrill Jantzi ^b   Pinto, Carissa ^c   Townsend Akpan, Carleen ^d   Leach, Eileen Enny ^e  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Dermatology and Allergy Associates

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

Contraceptive agents, female; Isotretinoin; Skin diseases; Teratogens

Indexed keywords

CONTRACEPTIVE AGENT; DERMATOLOGICAL AGENT; ISOTRETINOIN; TERATOGENIC AGENT;

ADULT; CONGENITAL MALFORMATION; DRUG CONTRAINDICATION; FEMALE; HUMAN; PREGNANCY; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SKIN DISEASE;

ABNORMALITIES; ADULT; CONTRACEPTIVE AGENTS, FEMALE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; PREGNANCY; RISK FACTORS; SEXUAL BEHAVIOR; SKIN DISEASES; TERATOGENS;

EID: 0035261389     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. Reed BR: Dermatologic drug use during pregnancy and lactation. Dermatol Clin 1997;15:197-206
2. Zeldis JB, Williams BA, Thomas AD, et al: S.T.E.P.S.: A comprehensive program for controlling and monitoring access to thalidomide. Clin Ther 1999;21:319-330
3. Reed BR: Dermatologic drugs, pregnancy, and lactation: A conservative guide. Arch Dermatol 1997;133:894-898
4. Enns GM, Roerder E, Chan RT, et al: Apparent cyclophosphamide (cytoxan) embryopathy: A distinct phenotype? Am J Med Genet 1999;86:237-241
5. Mitchell AA: Teratogens and the dermatologist (edit). Arch Dermatol 1991;127:399-401
6. Hönigsmann H, Szeimies R-M, Knobler R, et al: Photochemotherapy and photodynamic therapy. In Fitzpatrick's Dermatology in General Medicine. Edited by IM Freedberg, AZ Eisen, K Wolff, et al. Fifth edition. New York, McGraw-Hill, 1999, pp 2880-2900
7. Dutz JP, Ho VC: Immunosuppressive agents in dermatology: An update. Dermatol Clin 1998;16:235-251
8. Bilsland DJ, Rhodes LE, Zaki I, et al: PUVA and methotrexate therapy of psoriasis: How closely do dermatology departments follow treatment guidelines? Br J Dermatol 1994; 131:220-225
9. USP Dispensing Information. Volume 1: Drug Information for the Health Care Professional. Englewood, Colorado, Micromedex, 2000
10. Briggs GG, Freeman RK, Yaffe SJ: Drugs in Pregnancy and Lactation. Fifth edition. Baltimore, Williams & Wilkins, 1998
11. Gebbie AE, Glasier A, Sweeting V: Incidence of ovulation in perimenopausal women before and during hormone replacement therapy. Contraception 1995;52:221-222
12. Rosenthal SL, Burklow KA, Biro FM, et al: The reliability of high-risk adolescent girls' report of their sexual history. J Pediatr Health Care 1996;10:217-220
13. Brunton SA: Physicians as patient teachers. West J Med 1984;141:855-860
14. Alan Guttmacher Institute: Risks and prevention of unintended pregnancy and STDs. In Sex and America's Teenagers. New York, AGI, 1994
15. Center for Reproductive Law and Policy: Forced parental notification or consent defeats the goals of Title X family planning, 1999. http://www.crlp.org/titlex.htm
16. Westhoff C, Davis A: Tubal sterilization: Focus on the U.S. experience. Fertil Steril 2000;73:913-922
17. Schwingl PJ, Guess HA: Safety and effectiveness of vasectomy. Fertil Steril 2000;73:923-936
18. Glasier A: Emergency postcoital contraception. N Engl J Med 1997;337:1058-1064
19. Schnare SM: Emergency postcoital contraception. Am J Nurse Pract 2000;4:15-22
20. Guest F: Education and counseling. In Contraceptive Technology. Seventeenth edition. Edited by RA Hatcher, J Trussell, F Stewart, et al. New York, Ardent Media, 1998, pp 249-261
21. Mitchell AA, Bennekom CMVB, Louik C: A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333:101-106
22. Orfanos CE, Zouboulis CC, Almond-Roesler B, et al: Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-388
23. Physicians' Desk Reference. Fifty-fourth edition. Montvale, New Jersey, Medical Economics Company, Inc, 2000, pp 1423-1427